Xuan Q - Search Results

1

The clinicopathological and prognostic significance of PD-L1 expression in gastric cancer: a meta-analysis of 10 studies with 1,901 patients.

Zhang M, Dong Y, Liu H, Wang Y, Zhao S, Xuan Q, Wang Y, Zhang Q. Zhang M, et al. Among authors: xuan q. Sci Rep. 2016 Nov 28;6:37933. doi: 10.1038/srep37933. Sci Rep. 2016. PMID: 27892511 Free PMC article.

2

Identification of proteins responsible for adriamycin resistance in breast cancer cells using proteomics analysis.

Wang Z, Liang S, Lian X, Liu L, Zhao S, Xuan Q, Guo L, Liu H, Yang Y, Dong T, Liu Y, Liu Z, Zhang Q. Wang Z, et al. Among authors: xuan q. Sci Rep. 2015 Mar 30;5:9301. doi: 10.1038/srep09301. Sci Rep. 2015. PMID: 25818003 Free PMC article.

3

Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis.

Dong T, Liu Z, Xuan Q, Wang Z, Ma W, Zhang Q. Dong T, et al. Among authors: xuan q. Sci Rep. 2017 Jul 20;7(1):6069. doi: 10.1038/s41598-017-06378-7. Sci Rep. 2017. PMID: 28729678 Free PMC article.

4

Altered glycometabolism affects both clinical features and prognosis of triple-negative and neoadjuvant chemotherapy-treated breast cancer.

Dong T, Kang X, Liu Z, Zhao S, Ma W, Xuan Q, Liu H, Wang Z, Zhang Q. Dong T, et al. Among authors: xuan q. Tumour Biol. 2016 Jun;37(6):8159-68. doi: 10.1007/s13277-015-4729-8. Epub 2015 Dec 29. Tumour Biol. 2016. PMID: 26715276

5

The prognostic and predictive value of the lymphocyte to monocyte ratio in luminal-type breast cancer patients treated with CEF chemotherapy.

Ji H, Xuan Q, Yan C, Liu T, Nanding A, Zhang Q. Ji H, et al. Among authors: xuan q. Oncotarget. 2016 Jun 7;7(23):34881-9. doi: 10.18632/oncotarget.8993. Oncotarget. 2016. PMID: 27145456 Free PMC article.

6

Adherence to Needed Adjuvant Therapy Could Decrease Recurrence Rates for Rural Patients With Early Breast Cancer.

Xuan Q, Gao K, Song Y, Zhao S, Dong L, Zhang Z, Zhang Q, Wang J. Xuan Q, et al. Clin Breast Cancer. 2016 Dec;16(6):e165-e173. doi: 10.1016/j.clbc.2016.07.006. Epub 2016 Jul 28. Clin Breast Cancer. 2016. PMID: 27544692

7

Jagged1 promotes aromatase inhibitor resistance by modulating tumor-associated macrophage differentiation in breast cancer patients.

Liu H, Wang J, Zhang M, Xuan Q, Wang Z, Lian X, Zhang Q. Liu H, et al. Among authors: xuan q. Breast Cancer Res Treat. 2017 Nov;166(1):95-107. doi: 10.1007/s10549-017-4394-2. Epub 2017 Jul 20. Breast Cancer Res Treat. 2017. PMID: 28730338

8

Lymphocyte-Activation Gene-3 Expression and Prognostic Value in Neoadjuvant-Treated Triple-Negative Breast Cancer.

Wang Y, Dong T, Xuan Q, Zhao H, Qin L, Zhang Q. Wang Y, et al. Among authors: xuan q. J Breast Cancer. 2018 Jun;21(2):124-133. doi: 10.4048/jbc.2018.21.2.124. Epub 2018 Jun 20. J Breast Cancer. 2018. PMID: 29963107 Free PMC article.

9

Systemic immune response associated with radiation therapy in B‑cell non‑Hodgkin's lymphoma of Waldeyer's ring.

Niu X, Ji H, Wang Y, Hu S, Xuan Q, Huang L, Yin L, Su W, Li L, Zhang H, Li J, Yang Y, An W, Zhang Q. Niu X, et al. Among authors: xuan q. Oncol Rep. 2018 Dec;40(6):3674-3684. doi: 10.3892/or.2018.6748. Epub 2018 Sep 28. Oncol Rep. 2018. PMID: 30272309

10

The clinical implication of soluble PD-L1 (sPD-L1) in patients with breast cancer and its biological function in regulating the function of T lymphocyte.

Han B, Dong L, Zhou J, Yang Y, Guo J, Xuan Q, Gao K, Xu Z, Lei W, Wang J, Zhang Q. Han B, et al. Among authors: xuan q. Cancer Immunol Immunother. 2021 Oct;70(10):2893-2909. doi: 10.1007/s00262-021-02898-4. Epub 2021 Mar 10. Cancer Immunol Immunother. 2021. PMID: 33688997 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters